Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription 29.09.2025 1 Am J Surg 1 Ann Oncol 6 Ann Surg Oncol 4 Br J Cancer 3 Breast Cancer 2 Breast Cancer (Dove Med Press) 1 Breast Cancer Res Treat 4 Cancer 1 Cancer Epidemiol Biomarkers Prev 3 Cancer Res 5 Clin Breast Cancer 2 Clin Cancer Res 1 Clin Exp Metastasis 3 Eur J Cancer 1 Eur J Surg Oncol 1 Int J Cancer 1 Int J Oncol 1 J Natl Cancer Inst 3 J Surg Oncol 1 Mod Pathol 1 Oncogene 1 PLoS Comput Biol 3 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. PADMANABAN V, Bhattacharyya O, Stephens J, Fisher JL, et al
   Refusal of recommended breast cancer surgery: Trends after the Affordable Care Act and medicaid insurance expansion.
   Am J Surg. 2025 Sep 16:116609. doi: 10.1016/j.amjsurg.2025.116609.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. CHEN N, Freeman JQ, Yarlagadda S, Atmakuri A, et al
   Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer.
   Ann Oncol. 2025 Sep 17:S0923-7534(25)00922-6. doi: 10.1016/j.annonc.2025.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. DOUGLAS SR, van den Bruele AMB, Chiba A
   ASO Author Reflections: Lessons Learned from Neoadjuvant Endocrine Therapy use for Estrogen Receptor Positive Breast Cancer during the Covid-19 Pandemic.
   Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18380.
   PubMed        
   
   
4. MUNCK F, Tvedskov THF
   Reply to "Comment on TAD Outcomes from the Danish Breast Cancer Group Database".
   Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18419.
   PubMed        
   
   
5. DOUGLAS SR, Thomas SM, Chiba A, DiNome ML, et al
   Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
   Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18225.
   PubMed         Abstract available
   
   
6. DOUGLAS SR, Thomas SM, van den Bruele AB, Wang T, et al
   Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.
   Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18307.
   PubMed         Abstract available
   
   
7. WAGNER BD, Rubin J, Boe LA, Diwan R, et al
   Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy.
   Ann Surg Oncol. 2025 Sep 19. doi: 10.1245/s10434-025-18334.
   PubMed         Abstract available
   
   
8. BIRGIN E, Rahbari NN
   Robotic Central Hepatectomy.
   Ann Surg Oncol. 2025;32:7252-7253.
   PubMed         Abstract available
   
   

   
   Br J Cancer

9. CUZICK J, Dowsett M
   Oestradiol and breast cancer prevention: a 40 year history and contemporary perspective.
   Br J Cancer. 2025 Sep 19. doi: 10.1038/s41416-025-03115.
   PubMed         Abstract available
   
   
10. CHANG YH, Bresnahan ST, Taylor Head S, Harrison TA, et al
    Isoform-level analyses of 6 cancers uncover extensive genetic risk mechanisms undetected at the gene-level.
    Br J Cancer. 2025;133:874-885.
    PubMed         Abstract available
    
    
11. FICORELLA L, Yang X, Mavaddat N, Carver T, et al
    Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK population.
    Br J Cancer. 2025 Jul 17. doi: 10.1038/s41416-025-03117.
    PubMed         Abstract available
    
    
12. THONG MSY, Doege D, Koch-Gallenkamp L, Bertram H, et al
    Fatigue in long-term cancer survivors: prevalence, associated factors, and mortality. A prospective population-based study.
    Br J Cancer. 2025;133:831-843.
    PubMed         Abstract available
    
    

    
    Breast Cancer

13. JIANG W, Li Y
    A dynamic nomogram predicting persistent breast cancer-related lymphedema: a retrospective cohort study in China.
    Breast Cancer. 2025 Sep 22. doi: 10.1007/s12282-025-01781.
    PubMed         Abstract available
    
    
14. LI X, Huang T
    Advances in the intrinsic signaling pathway interactions and clinical translation of HR+/HER2+ breast cancer.
    Breast Cancer. 2025 Sep 22. doi: 10.1007/s12282-025-01779.
    PubMed         Abstract available
    
    
15. FUTAMURA M, Nagao Y, Takai Y, Niwa Y, et al
    Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancer.
    Breast Cancer. 2025 Sep 22. doi: 10.1007/s12282-025-01775.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

16. YUAN J, Xin F, Wang R
    ANXA2 Regulates RANKL-Induced Osteoclast Differentiation Through STAT3 Signaling in Breast Cancer.
    Breast Cancer (Dove Med Press). 2025;17:837-849.
    PubMed         Abstract available
    
    
17. XU J, Long J, Li ZY, Wang C, et al
    Effects of Clinacanthus nutans Extracts on Cell Proliferation and Apoptosis in Triple-Negative Breast Cancer: Mechanistic Insights.
    Breast Cancer (Dove Med Press). 2025;17:819-835.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

18. ZAGO A, Leveque E, Augustynen A, Leheurteur M, et al
    Correction: Analysis of the impact of the COVID-19 pandemic on the stage at diagnosis in breast cancer patients at a French comprehensive cancer centre, through two different methods: a preliminary study.
    Breast Cancer Res Treat. 2025 Sep 23. doi: 10.1007/s10549-025-07813.
    PubMed        
    
    

    
    Cancer

19. ISLAMI F, Wiese D, Schafer EJ, Sung H, et al
    Stage-specific cancer survival in Black and White persons by urbanicity of county of residence, United States, 2015-2021.
    Cancer. 2025;131:e70073.
    PubMed         Abstract available
    
    
20. RIBI K, Cole BF, Fleming GF, Walley BA, et al
    Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.
    Cancer. 2025;131:e70094.
    PubMed         Abstract available
    
    
21. COLAES R, Schroyen G, Radwan A, Gavrila Laic RA, et al
    Unveiling the impact of chemotherapy in patients with breast cancer: A longitudinal study on peripheral inflammation, multimodal magnetic resonance imaging, and cognition.
    Cancer. 2025;131:e70095.
    PubMed         Abstract available
    
    
22. SHAFFER KM, Daniel KE, Wiseman KP, Ritterband LM, et al
    Prospective associations between sleep quality and sexual satisfaction in distressed breast cancer survivors: Secondary analysis from the Apps Reaching Cancer Survivors randomized trial.
    Cancer. 2025;131:e70093.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

23. WANG X, Yang X, Chen R, Liu W, et al
    Aspirin Use and Risk of Breast Cancer Recurrence in Chinese Patients.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed         Abstract available
    
    

    
    Cancer Res

24. KHAN F, Petrosyan E, Liu Y, Bahrami A, et al
    Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis.
    Cancer Res. 2025 Sep 18. doi: 10.1158/0008-5472.CAN-25-1791.
    PubMed         Abstract available
    
    
25. LIU P, Zheng J, Ma W, Lu J, et al
    Stress Promotes Lung Metastasis in Breast Cancer by Altering Neutrophil Differentiation.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-25-1763.
    PubMed         Abstract available
    
    
26. LIU J, Fang F, Yuan W, Chen T, et al
    Integrating Circulating Tumor DNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-25-0608.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

27. MEZGHANI M, Ben Rejeb M, Hamdoun A, Haddad R, et al
    Real World Safety of Adjuvant Ultra Hypofractionated Radiotherapy in Nonmetastatic Breast Cancer: Acute Cutaneous Toxicity and Aesthetic Outcomes.
    Clin Breast Cancer. 2025 Aug 19:S1526-8209(25)00234.
    PubMed         Abstract available
    
    
28. MOHAMED IK, Abbassi MM, Kelany MR, Farid SF, et al
    Efficacy of Topical Betamethasone Valerate and Olive Oil in Preventing Acute Radiation Dermatitis in Breast Cancer: A Randomized Double-Blind Placebo-Controlled Study.
    Clin Breast Cancer. 2025 Aug 21:S1526-8209(25)00235.
    PubMed         Abstract available
    
    
29. WANG Y, Ma L, Yuan S, Wang Z, et al
    Multiomics Analysis for Predicting Pathological Complete Response in Triple-Negative Breast Cancer and Reflecting Tumor Heterogeneity.
    Clin Breast Cancer. 2025 Aug 22:S1526-8209(25)00241.
    PubMed         Abstract available
    
    
30. JAFFER AA, Cullinane C, Davey MG, Jalali A, et al
    Evaluating the Neutrophil-Lymphocyte Ratio as a Predictor of Long-Term Oncological and Survival Outcomes in Patients Treated Surgically for Breast Cancer.
    Clin Breast Cancer. 2025 Aug 24:S1526-8209(25)00243.
    PubMed         Abstract available
    
    
31. HUANG PL, Mysore MM, Barr B, Onukwugha E, et al
    Relationship Between Census Tract-Level Social Determinants of Health and Cardiovascular Care among Individuals Diagnosed With Breast Cancer.
    Clin Breast Cancer. 2025 Aug 26:S1526-8209(25)00247.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

32. REED SC, Potts CR, Luo L, Davidson BA, et al
    Clonal hematopoiesis of indeterminate potential influences breast cancer outcomes in a genotype-specific manner.
    Clin Cancer Res. 2025 Sep 19. doi: 10.1158/1078-0432.CCR-25-2009.
    PubMed         Abstract available
    
    
33. GUIU S, Balmana J, Lemercier P, Follana P, et al
    Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER+/HER2- breast cancer and selected genomic alterations: results of the DOLAF trial.
    Clin Cancer Res. 2025 Sep 23. doi: 10.1158/1078-0432.CCR-24-4221.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

34. NATHANSON SD, Dieterich LC, Zhang XH, Chitale DA, et al
    Correction: Associations amongst genes, molecules, cells, and organs in breast cancer metastasis.
    Clin Exp Metastasis. 2025;42:55.
    PubMed        
    
    

    
    Eur J Cancer

35. ALTUNDAG K
    Letter Re: Impact of early discontinuation of adjuvant endocrine therapy on survival in breast cancer: A target trial emulation.
    Eur J Cancer. 2025;229:115780.
    PubMed        
    
    
36. WANG ZN, Tian GH, Ding JR, Lin Y, et al
    Acupuncture effect on brain default mode network connectivity in breast cancer patients with hot flashes: A randomized controlled trial.
    Eur J Cancer. 2025;229:115785.
    PubMed         Abstract available
    
    
37. MOUSTAQUIM J, van Wonderen GE, van Geel JJL, van Kruchten M, et al
    Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer.
    Eur J Cancer. 2025;229:115792.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

38. REIMER T, Kuehn T, Mueller V, Ditsch N, et al
    AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
    Eur J Surg Oncol. 2025;51:110445.
    PubMed         Abstract available
    
    

    
    Int J Cancer

39. WANG DQ, Shen DX, Han N, Lu YF, et al
    Dosimetric and clinical predictors for radiation esophagitis in patients with breast cancer undergoing conventional fractionated regional nodal irradiation: A prospective study.
    Int J Cancer. 2025 Sep 18. doi: 10.1002/ijc.70161.
    PubMed         Abstract available
    
    

    
    Int J Oncol

40. HUA K, Jin J, Zhao J, Song J, et al
    [Expression of Concern] miR?135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Int J Oncol. 2025;67:96.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

41. SEEWALDT VL, Schedin PJ
    Breastfeeding after breast cancer: a need for further mechanistic study.
    J Natl Cancer Inst. 2025 Sep 18:djaf240. doi: 10.1093.
    PubMed        
    
    

    
    J Surg Oncol

42. NGUYEN AT, Li RA, Ontiveros NC, Adam TH, et al
    Utility of the Social Vulnerability Index in Addressing Breast Cancer Disparities: A Meta-Analysis.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70080.
    PubMed         Abstract available
    
    
43. ZHANG X, Chen Y, Wu Q, Yu Y, et al
    Safety Analysis of Omitting Radiotherapy After Breast-Conserving Surgery in Patients With Early-Stage Breast Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70091.
    PubMed         Abstract available
    
    
44. REDAELLI M, Steadman JA, Hoskin TL, Hieken TJ, et al
    Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo-Immunotherapy in Breast Cancer?
    J Surg Oncol. 2025 Sep 24. doi: 10.1002/jso.70096.
    PubMed         Abstract available
    
    

    
    Mod Pathol

45. FLORIS G, Djerroudi L, Zels G, De Schepper M, et al
    Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast.
    Mod Pathol. 2025;38:100837.
    PubMed         Abstract available
    
    

    
    Oncogene

46. CAI Y, Du J, Wang H, Shen L, et al
    KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair.
    Oncogene. 2025 Sep 18. doi: 10.1038/s41388-025-03503.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

47. NOUIRA A, Azencott CA
    Sparse multitask group Lasso for genome-wide association studies.
    PLoS Comput Biol. 2025;21:e1012734.
    PubMed         Abstract available
    
    

    
    PLoS One

48. TUNA BG, Keles NA, Cicekdal MB, Dogan S, et al
    Distinct transcriptomic effects of intermittent and chronic caloric restriction in mammary fat pad of a breast cancer mouse model.
    PLoS One. 2025;20:e0331898.
    PubMed         Abstract available
    
    
49. SOETOMO SA, Sharp MF, Crismani W
    Differential PARP inhibitor responses in BRCA1-deficient and resistant cells in competitive co-culture.
    PLoS One. 2025;20:e0332860.
    PubMed         Abstract available
    
    
50. GUZMAN-LORITE M, Munoz-Moreno L, Marina ML, Carmena MJ, et al
    In vitro and in vivo approaches demonstrating the antiproliferative activity of pomegranate seed proteins and peptides on breast cancer.
    PLoS One. 2025;20:e0330895.
    PubMed         Abstract available
    
    

    
    Radiology

51. HRUSKA CB, Hunt KN, Larson NB, Miller PA, et al
    Molecular Breast Imaging and Digital Breast Tomosynthesis for Dense Breast Screening: The Density MATTERS Trial.
    Radiology. 2025;316:e243953.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.